Novartis Targets Oncology Leadership with $1.5B Acquisition of ADC Innovator Myricx Bio
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...